-
公开(公告)号:US6140312A
公开(公告)日:2000-10-31
申请号:US466714
申请日:1995-06-06
申请人: Rudolf Edger Falk , Samuel Simon Asculai , David Hochman , Don Purschke , Ehud Shmuel Klein , David William Harper
发明人: Rudolf Edger Falk , Samuel Simon Asculai , David Hochman , Don Purschke , Ehud Shmuel Klein , David William Harper
IPC分类号: A61K9/00 , A61K31/192 , A61K31/196 , A61K31/405 , A61K31/407 , A61K31/455 , A61K31/513 , A61K31/5415 , A61K31/70 , A61K31/715 , A61K31/728 , A61K31/765 , A61K47/22 , A61K47/36 , A61P29/00
CPC分类号: A61K31/616 , A61K31/192 , A61K31/196 , A61K31/405 , A61K31/407 , A61K31/455 , A61K31/513 , A61K31/5415 , A61K31/70 , A61K31/715 , A61K31/728 , A61K47/36 , A61K9/0014
摘要: The invention relates to a method of rapidly transporting a drug to the epidermis and accumulating and maintaining the drug therein for a prolonged period of time comprising administration of a therapeutically efective non-toxic amount of the drug with an effective amount of hyaluronic acid.
摘要翻译: 本发明涉及一种将药物快速输送到表皮并在其中积累和维持药物持续较长时间的方法,包括用有效量的透明质酸施用治疗有效量的无毒量的药物。
-
公开(公告)号:US5990096A
公开(公告)日:1999-11-23
申请号:US466713
申请日:1995-06-06
申请人: Samuel Simon Asculai , David Hochman , Don Purschke , David William Harper , Ehud Shmuel Klein , Rudolf Edger Falk
发明人: Samuel Simon Asculai , David Hochman , Don Purschke , David William Harper , Ehud Shmuel Klein , Rudolf Edger Falk
IPC分类号: A61K9/00 , A61K31/192 , A61K31/196 , A61K31/405 , A61K31/407 , A61K31/455 , A61K31/513 , A61K31/5415 , A61K31/70 , A61K31/715 , A61K31/728 , A61K47/36
CPC分类号: A61K31/616 , A61K31/192 , A61K31/196 , A61K31/405 , A61K31/407 , A61K31/455 , A61K31/513 , A61K31/5415 , A61K31/70 , A61K31/715 , A61K31/728 , A61K47/36 , A61K9/0014
摘要: The invention relates to a method of controlling the unloading of a drug from the skin or exposed tissue of a human into the lymphatic system comprising transporting an effective dosage amount of the drug into the skin or exposed tissue by an effective non-toxic amount of a form of hyaluronic acid.
摘要翻译: 本发明涉及一种控制将药物从人的皮肤或暴露组织卸载到淋巴系统中的方法,包括将有效剂量的药物通过有效的无毒量的药物输送到皮肤或暴露的组织中 形式的透明质酸。
-
公开(公告)号:US06218373B1
公开(公告)日:2001-04-17
申请号:US08467994
申请日:1995-06-06
申请人: Rudolf Edger Falk , Samuel Simon Asculai , David Hochman , Don Purschke , Ehud Shmuel Klein , David William Harper
发明人: Rudolf Edger Falk , Samuel Simon Asculai , David Hochman , Don Purschke , Ehud Shmuel Klein , David William Harper
IPC分类号: A61K31715
CPC分类号: A61K31/616 , A61K9/0014 , A61K31/192 , A61K31/196 , A61K31/405 , A61K31/407 , A61K31/455 , A61K31/513 , A61K31/5415 , A61K31/70 , A61K31/715 , A61K31/728 , A61K47/36 , A61K2300/00
摘要: A method of treating a disease of condition administering topically to the skin or exposed tissue of a human, a dosage amount of a pharmaceutical composition, said dosage comprising a therapeutically effective amount of a drug to treat said disease or condition and a form of hyaluronic acid characterized in that the composition is immediately available to transport the drug percutaneously into the epidermis of the skin or exposed tissue to the site of trauma or pathology of the disease or condition to be treated.
摘要翻译: 治疗局部给予人的皮肤或暴露组织的病症的疾病的方法,药物组合物的剂量,所述剂量包含治疗有效量的治疗所述疾病或病症的药物和一种形式的透明质酸 其特征在于,该组合物可立即用于将药物经皮输送到皮肤或暴露组织的表皮中至要治疗的疾病或病症的创伤或病理部位。
-
公开(公告)号:US6136793A
公开(公告)日:2000-10-24
申请号:US466715
申请日:1995-06-06
申请人: Rudolf Edger Falk , Samuel Simon Asculai , David Hochman , Don Purschke , Ehud Shmuel Klein , David William Harper
发明人: Rudolf Edger Falk , Samuel Simon Asculai , David Hochman , Don Purschke , Ehud Shmuel Klein , David William Harper
IPC分类号: A61K9/00 , A61K31/192 , A61K31/196 , A61K31/405 , A61K31/407 , A61K31/455 , A61K31/513 , A61K31/5415 , A61K31/70 , A61K31/715 , A61K31/728 , A61K47/36
CPC分类号: A61K31/616 , A61K31/192 , A61K31/196 , A61K31/405 , A61K31/407 , A61K31/455 , A61K31/513 , A61K31/5415 , A61K31/70 , A61K31/715 , A61K31/728 , A61K47/36 , A61K9/0014
摘要: A method of treating a disease or condition comprising administering topically to the skin or exposed tissue of a human, a dosage amount of a pharmaceutical composition, said dosage comprising a therapeutically effective amount of a drug to treat said disease or condition and a form of hyaluronic acid characterized in that the composition is immediately available to transport the drug percutaneously into the epidermis of the skin or exposed tissue to the site of trauma or pathology of the disease or condition to be treated.
摘要翻译: 一种治疗疾病或病症的方法,包括对皮肤或暴露于人体的组织局部施用药物组合物的剂量,所述剂量包含治疗有效量的治疗所述疾病或病症的药物和透明质酸的形式 酸的特征在于,该组合物可立即用于将药物经皮输送到皮肤或暴露组织的表皮中至要治疗的疾病或病症的创伤或病理部位。
-
公开(公告)号:US5977088A
公开(公告)日:1999-11-02
申请号:US467995
申请日:1995-06-06
申请人: David William Harper , Ehud Shmuel Klein , Rudolf Edger Falk , Samuel Simon Asculai , David Hochman , Don Purschke
发明人: David William Harper , Ehud Shmuel Klein , Rudolf Edger Falk , Samuel Simon Asculai , David Hochman , Don Purschke
IPC分类号: A61K31/192 , A61K31/196 , A61K31/405 , A61K31/70 , A61K31/715 , A61K31/728 , A61K45/06
CPC分类号: A61K31/728 , A61K31/192 , A61K31/196 , A61K31/405 , A61K31/70 , A61K31/715 , A61K45/06
摘要: Pharmaceutical compositions from which effective non-toxic (to the patient) dosage amounts may be taken and applied to the skin and/or exposed tissue of a human, each effective dosage amount comprising pharmaceutical excipients suitable for topical application, an effective non-toxic dosage amount of a drug to treat and to assist to resolve a disease and/or condition of the skin and/or exposed tissue of a human and an effective non-toxic dosage amount of hyaluronic acid and/or salts thereof and/or homologues, analogues, derivatives, complexes, esters, fragments, and/or sub-units of hyaluronic acid sufficient to transport (to facilitate or cause the transport of) the drug, to a site in the skin including epidermis or exposed tissue of a disease or condition for percutaneous transport into the skin and/or exposed tissue to accumulate and remain there for a prolonged period of time and which is systemic independent acting.
-
公开(公告)号:US5942498A
公开(公告)日:1999-08-24
申请号:US467171
申请日:1995-06-06
申请人: Rudolf Edger Falk , Samuel Simon Asculai , Ehud Shmuel Klein , David William Harper , David Hochman , Don Purschke
发明人: Rudolf Edger Falk , Samuel Simon Asculai , Ehud Shmuel Klein , David William Harper , David Hochman , Don Purschke
IPC分类号: A61K9/00 , A61K31/192 , A61K31/196 , A61K31/405 , A61K31/407 , A61K31/455 , A61K31/513 , A61K31/5415 , A61K31/70 , A61K31/715 , A61K31/728 , A61K47/36
CPC分类号: A61K31/616 , A61K31/192 , A61K31/196 , A61K31/405 , A61K31/407 , A61K31/455 , A61K31/513 , A61K31/5415 , A61K31/70 , A61K31/715 , A61K31/728 , A61K47/36 , A61K9/0014
摘要: Topically applied transdermally quick penetrating compositions containing a drug and hyaluronic acid and/or salts thereof and methods of treating diseases and conditions employing said compositions.
摘要翻译: 包含药物和透明质酸和/或其盐的局部应用的经皮快速渗透组合物和使用所述组合物治疗疾病和病症的方法。
-
公开(公告)号:US6103704A
公开(公告)日:2000-08-15
申请号:US18754
申请日:1993-02-17
申请人: Rudolf Edgar Falk , Samuel Simon Asculai , Ehud Shmuel Klein , David William Harper , David Hochman , Don Purschke
发明人: Rudolf Edgar Falk , Samuel Simon Asculai , Ehud Shmuel Klein , David William Harper , David Hochman , Don Purschke
IPC分类号: A61K9/00 , A61K31/19 , A61K31/192 , A61K31/196 , A61K31/405 , A61K31/407 , A61K31/44 , A61K31/455 , A61K31/5415 , A61K31/715 , A61K31/728 , A61K45/06 , A61K47/00 , A61K47/36 , A61K31/725
CPC分类号: A61K9/0014 , A61K31/19 , A61K31/192 , A61K31/196 , A61K31/405 , A61K31/407 , A61K31/44 , A61K31/455 , A61K31/503 , A61K31/5415 , A61K31/616 , A61K31/715 , A61K31/728 , A61K45/06 , A61K47/36
摘要: A method of accumulating a drug and a form of hyaluronic acid in the skin and/or exposed tissue of a human includes topically administering a therapeutically effective dosage amount of a formulation which comprises at least 5 mg/cm.sup.2 of the form of hyaluronic acid and a therapeutically effective amount of the drug.
摘要翻译: 在人的皮肤和/或暴露组织中积聚药物和形式的透明质酸的方法包括局部施用治疗有效剂量的制剂,其包含至少5mg / cm 2的透明质酸形式和 治疗有效量的药物。
-
公开(公告)号:US6114314A
公开(公告)日:2000-09-05
申请号:US352697
申请日:1994-12-01
申请人: Rudolf Edgar Falk , Samuel Simon Asculai , Ehud Shmuel Klein , David W. Harper , David Hochman , Don Purschke
发明人: Rudolf Edgar Falk , Samuel Simon Asculai , Ehud Shmuel Klein , David W. Harper , David Hochman , Don Purschke
IPC分类号: A61K31/70
CPC分类号: A61K9/0014 , A61K31/133 , A61K31/192 , A61K31/196 , A61K31/405 , A61K31/44 , A61K31/5415 , A61K47/36 , A61K9/06
摘要: Topically applied transdermally quick penetrating (best targeting the epidermis and subsequently remaining there for a prolonged period of time) systemic independent acting, combinations and formulations which employ, combine, or incorporate a therapeutically effective non-toxic (to the patient) amount of a drug which inhibits prostaglandin synthesis together with an amount of hyaluronic acid and/or salts thereof (for example the sodium salt) and/or homologues, analogues, derivatives, complexes, esters, fragments, and/or sub units of hyaluronic acid to treat a disease and condition of the skin and exposed tissue for example, basal cell carcinoma, the precancerous, often recurrent, actinic keratoses lesions, fungal lesions, "liver" spots and like lesions (found for the most part in the epidermis), squamous cell tumours, metastatic cancer of the breast to the skin, primary and metastatic melanoma in the skin, genital warts cervical cancer, and HPV (Human Papilloma Virus) including HPV of the cervix, psoriasis (both plaque-type psoriasis and nail bed psoriasis), corns on the feet and hair loss on the head of pregnant women and remain in the skin for a prolonged period of time.
摘要翻译: 局部应用经皮快速穿透(最佳靶向表皮,随后长时间保留)系统性独立作用,组合和制剂,其使用,组合或并入治疗有效的无毒(至患者)量的药物 其与一定量的透明质酸和/或其盐(例如钠盐)和/或透明质酸的同系物,类似物,衍生物,复合物,酯,片段和/或亚单位一起抑制前列腺素合成以治疗疾病 皮肤和暴露组织的状况,例如基底细胞癌,癌前期,经常复发的光化性角化病变,真菌病变,“肝”斑点和类似病变(在大部分表皮中发现),鳞状细胞肿瘤, 乳腺对皮肤的转移性癌症,皮肤原发性和转移性黑素瘤,生殖器疣宫颈癌和HPV(人乳头状瘤病毒)包括HPV的HPV 子宫颈,牛皮癣(斑块型牛皮癣和指甲银屑病),脚上的玉米和孕妇头部的脱发,并长时间保持在皮肤中。
-
公开(公告)号:US5674857A
公开(公告)日:1997-10-07
申请号:US200309
申请日:1994-02-23
IPC分类号: A61K31/728 , A61K31/70
CPC分类号: A61K31/728
摘要: A pharmaceutical composition comprising an effective non-toxic amount of hyaluronic acid (HA) and or salts thereof and/or homologues, analogues, derivatives, complexes, esters, fragments and units of HA in association with a suitable diluent or pharmaceutically acceptable carrier for use in treating ischemia damage in tissue.
摘要翻译: 包含有效无毒量的透明质酸(HA)及其盐和/或与适用的稀释剂或药学上可接受的载体结合使用的HA的同系物,类似物,衍生物,复合物,酯,片段和单元的有效无毒量的药物组合物 治疗组织缺血损伤。
-
-
-
-
-
-
-
-